Saphnelo Dosage
Generic name: ANIFROLUMAB 300mg in 2.0mL
Dosage form: injection, solution
Drug class: Selective immunosuppressants
Medically reviewed by Drugs.com. Last updated on Aug 7, 2024.
Dosage Recommendations
SAPHNELO must be diluted prior to intravenous administration [see Dosage and Administration (2.2)].
The recommended dosage of SAPHNELO is 300 mg, administered as an intravenous infusion over a 30-minute period, every 4 weeks.
Missed dose
If a planned infusion is missed, administer SAPHNELO as soon as possible. Maintain a minimum interval of 14 days between infusions.
Instructions for Preparation and Administration
SAPHNELO is supplied as a single-dose vial. Prepare the diluted infusion solution using aseptic technique, by the following procedure:
- 1.
- Visually inspect the vial for particulate matter and discoloration. SAPHNELO is a clear to opalescent, colorless to slightly yellow, solution. Discard the vial if the solution is cloudy, discolored or visible particles are observed. Do not shake the vial.
- 2.
- Withdraw and discard 2 mL of solution from a 50 mL or 100 mL 0.9% Sodium Chloride Injection, USP infusion bag.
- 3.
- Withdraw 2 mL of solution from the vial of SAPHNELO and add it to the infusion bag. Mix the solution by gentle inversion. Do not shake.
- 4.
- Each vial is intended for one time use only. Discard any unused portion remaining in the vial.
- 5.
- Administer the infusion solution immediately after preparation.
- 6.
- If the infusion solution is not administered immediately, store the diluted solution of SAPHNELO at room temperature (59°F to 77°F, 15°C to 25°C) for up to 4 hours, or refrigerated (36°F to 46°F, 2°C to 8°C) for up to 24 hours. Do not freeze. Protect from light. If refrigerated, allow the diluted SAPHNELO solution to reach room temperature prior to administration.
- 7.
- Administer the infusion solution intravenously over a 30-minute period through an infusion line containing a sterile, low-protein binding 0.2 to 15 micron in-line or add-on filter.
- 8.
- To ensure the complete dose of SAPHNELO has been administered, flush the entire infusion line with 25 mL of 0.9% Sodium Chloride Injection, USP at the end of the infusion.
- 9.
- Do not co-administer other medicinal products through the same infusion line.
- 10.
- Dispose of any unused medicinal product or waste material in accordance with local requirements.
Frequently asked questions
More about Saphnelo (anifrolumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.